Back

The effect of treatment srategy for acute myocardial infarction complicated by cardiac shock using Impella in accordance with institutional protocol

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Management and prognostication in acute myocardial infarction cardiogenic shock Shock ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Takeshi Tada

Kurashiki Central Hospital, Kurashiki (Japan)

4 More presentations in this session

Presentation thumbnail
Influence of hospital ownership on patient outcomes in STEMI-induced cardiogenic shock undergoing revascularization: a retrospective cohort study
Doctor J. Sequeira Gross (Fort Myers, US)
Abstract Slides Video
Presentation thumbnail
Evaluation of repeated machine learning-based phenotyping in patients with cardiogenic shock
Doctor E. Zweck (Duesseldorf, DE)
Abstract Slides Video
Presentation thumbnail
Patient characteristics and clinical outcome in acute myocardial infarction related cardiogenic shock according to vascular access site for PCI
Mrs E. Peters (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Influence of timing of impella insertion on the prognosis of acute myocardial infarction complicated with cardiogenic shock requiring ECPELLA
Doctor K. Shimamoto (Kyoto, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Management and prognostication in acute myocardial infarction cardiogenic shock
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Outcome of patients with cardiogenic shock in acute myocardial infarction treated with Impella CP and a standardized protocol
thumbnail
Congress Presentation
Safety and mid-term outcomes of impella compared to intra-aortic balloon pumping in patients who required mechanical cardiac support
thumbnail
Congress Presentation
Impact of Impella5.0/5.5 use on short-term prognosis in patients with AMI-related cardiogenic shock receiving Impella-incorporated MCS in Japan

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources